PMID- 27234778 OWN - NLM STAT- MEDLINE DCOM- 20161223 LR - 20181202 IS - 1873-2623 (Electronic) IS - 0041-1345 (Linking) VI - 48 IP - 3 DP - 2016 Apr TI - Oxygen Uptake Efficiency Slope Predicts Major Cardiac Events in Patients With End-Stage Heart Failure. PG - 956-8 LID - S0041-1345(16)00125-1 [pii] LID - 10.1016/j.transproceed.2015.10.076 [doi] AB - INTRODUCTION: Oxygen uptake efficiency slope (OUES) has been shown as a predictor of stable heart failure (HF) survival. However, there is a lack of evidence for end-stage HF. OBJECTIVES: We aimed to investigate the prognostic value of OUES in end-stage HF patients. METHODS: The study design was a retrospective cohort. End-staged HF patients who had cardiopulmonary exercise testing (CPET) for evaluation between 2004 and 2009 were included. The primary outcomes were cardiac death and heart transplantation. The independent survival predictors were determined using Cox regression hazard model adjusted for demographics, New York Heart Association (NYHA) classification, medication, and left ventricular ejection fraction (LVEF). The Kaplan-Meier survival curves and log-rank test were used. Probability values less than .05 were considered significant. RESULTS: Mean age of the 128 patients was 50 +/- 12 years and 93 were male. Mean LVEF was 23% +/- 9%. Forty-three subjects suffered cardiac events (5 cardiac deaths and 38 urgent heart transplantations) during the 2-year follow-up period. Cox regression indicated that OUES and diuretics were significant predictors of 2-year survival, although peak oxygen uptake and ventilatory equivalent of carbon dioxide were not. Patients with high OUES (>/=1.6) had a higher survival rate (P < .001; odds ratio [OR], 13.10; 95% confidence interval [CI], 3.30-58.63). The Kaplan-Meier curves show survival was significantly higher in those with OUES >/=1.6. CONCLUSIONS: OUES might be an aid in prognosis of patients with end-stage HF and useful in the assessment of patients unable to perform maximal exercise testing. CI - Copyright (c) 2016 Elsevier Inc. All rights reserved. FAU - Lin, Y-S AU - Lin YS AD - Heart Center, Cheng Hsin General Hospital, Taipei, Taiwan. FAU - Huang, H-Y AU - Huang HY AD - Heart Center, Cheng Hsin General Hospital, Taipei, Taiwan. Electronic address: 856038@gmail.com. FAU - Lin, W-H AU - Lin WH AD - Heart Center, Cheng Hsin General Hospital, Taipei, Taiwan. FAU - Wei, J AU - Wei J AD - Heart Center, Cheng Hsin General Hospital, Taipei, Taiwan. FAU - Chen, J-C AU - Chen JC AD - Heart Center, Cheng Hsin General Hospital, Taipei, Taiwan. FAU - Kuo, L-Y AU - Kuo LY AD - Heart Center, Cheng Hsin General Hospital, Taipei, Taiwan. FAU - Hsu, C-L AU - Hsu CL AD - Heart Center, Cheng Hsin General Hospital, Taipei, Taiwan. FAU - Chen, B-Y AU - Chen BY AD - Heart Center, Cheng Hsin General Hospital, Taipei, Taiwan. FAU - Cheng, F-H AU - Cheng FH AD - Heart Center, Cheng Hsin General Hospital, Taipei, Taiwan. LA - eng PT - Journal Article PL - United States TA - Transplant Proc JT - Transplantation proceedings JID - 0243532 RN - S88TT14065 (Oxygen) SB - IM MH - Exercise Test MH - Female MH - Follow-Up Studies MH - Heart Failure/*metabolism/mortality/physiopathology MH - *Heart Transplantation MH - Humans MH - Kaplan-Meier Estimate MH - Male MH - Middle Aged MH - Oxygen/*metabolism MH - Oxygen Consumption/*physiology MH - Prognosis MH - Retrospective Studies MH - Survival Rate/trends MH - Taiwan/epidemiology MH - Ventricular Function, Left/physiology EDAT- 2016/05/29 06:00 MHDA- 2016/12/24 06:00 CRDT- 2016/05/29 06:00 PHST- 2015/09/17 00:00 [received] PHST- 2015/10/03 00:00 [accepted] PHST- 2016/05/29 06:00 [entrez] PHST- 2016/05/29 06:00 [pubmed] PHST- 2016/12/24 06:00 [medline] AID - S0041-1345(16)00125-1 [pii] AID - 10.1016/j.transproceed.2015.10.076 [doi] PST - ppublish SO - Transplant Proc. 2016 Apr;48(3):956-8. doi: 10.1016/j.transproceed.2015.10.076.